ACCELERON PHARMA INC Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for June 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 35.01 | 10,320 | 361,303 | 1,903,063 | 1.9 M to 1.9 M (-0.54 %) |
| Jun 27 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 35.00 | 171 | 5,985 | 1,913,383 | 1.9 M to 1.9 M (-0.01 %) |
| Jun 24 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 35.03 | 10,402 | 364,382 | 1,913,554 | 1.9 M to 1.9 M (-0.54 %) |
| Jun 24 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 35.27 | 13,618 | 480,307 | 1,923,956 | 1.9 M to 1.9 M (-0.70 %) |
| Jun 24 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 35.02 | 1,457 | 51,024 | 1,937,574 | 1.9 M to 1.9 M (-0.08 %) |
| Jun 24 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 5.88 | 5,000 | 29,400 | 15,000 | |
| Jun 24 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 35.00 | 7,000 | 245,000 | 37,890 | 44.9 K to 37.9 K (-15.59 %) |
| Jun 24 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 5.88 | 5,000 | 29,400 | 44,890 | 39.9 K to 44.9 K (+12.53 %) |
| Jun 20 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 34.13 | 500 | 17,065 | 32,500 | 33 K to 32.5 K (-1.52 %) |
| Jun 20 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 34.49 | 2,000 | 68,980 | 13,858 | 15.9 K to 13.9 K (-12.61 %) |
| Jun 19 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 3.88 | 8,000 | 31,040 | 54,500 | |
| Jun 19 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 3.88 | 8,000 | 31,040 | 35,656 | 27.7 K to 35.7 K (+28.93 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 5.28 | 2,740 | 14,467 | 16,010 | |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 3.88 | 4,260 | 16,529 | 51,240 | |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 0.92 | 2,000 | 1,840 | 21,500 | |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 34.13 | 2,700 | 92,151 | 0 | 2.7 K to 0 (-100.00 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 33.86 | 6,300 | 213,318 | 2,700 | 9 K to 2.7 K (-70.00 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 5.28 | 2,740 | 14,467 | 9,000 | 6.3 K to 9 K (+43.77 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 3.88 | 4,260 | 16,529 | 6,260 | 2 K to 6.3 K (+213.00 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 0.92 | 2,000 | 1,840 | 2,000 | 0 to 2 K |
| Jun 13 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 0.48 | 6,000 | 2,880 | 47,765 | |
| Jun 13 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 33.25 | 1,500 | 49,875 | 33,000 | 34.5 K to 33 K (-4.35 %) |
| Jun 13 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 33.23 | 6,000 | 199,380 | 15,858 | 21.9 K to 15.9 K (-27.45 %) |
| Jun 13 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 0.48 | 6,000 | 2,880 | 21,858 | 15.9 K to 21.9 K (+37.84 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 7,000 | 27,160 | 195,751 | |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 3,000 | 11,640 | 202,751 | |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.98 | 4,197 | 134,220 | 0 | 4.2 K to 0 (-100.00 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.16 | 2,803 | 87,341 | 4,197 | 7 K to 4.2 K (-40.04 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 7,000 | 27,160 | 7,000 | 0 to 7 K |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.00 | 1,686 | 53,952 | 0 | 1.7 K to 0 (-100.00 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.17 | 1,314 | 40,957 | 1,686 | 3 K to 1.7 K (-43.80 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 3,000 | 11,640 | 3,000 | 0 to 3 K |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.99 | 2,800 | 89,572 | 191,500 | 194.3 K to 191.5 K (-1.44 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.19 | 2,200 | 68,618 | 194,300 | 196.5 K to 194.3 K (-1.12 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.98 | 6,109 | 195,366 | 196,500 | 202.6 K to 196.5 K (-3.02 %) |
| Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.14 | 3,891 | 121,166 | 202,609 | 206.5 K to 202.6 K (-1.88 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Polaris Venture Management Co ... | 10% Owner | Sell | J | 0.00 | 198,005 | 0 | 2,621,738 | 2.8 M to 2.6 M (-7.02 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 29.72 | 2,000 | 59,440 | 39,890 | 41.9 K to 39.9 K (-4.77 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 9,375 | |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 7,500 | 38,100 | 41,250 | |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | S | 29.73 | 2,500 | 74,325 | 27,656 | 25.2 K to 27.7 K (+9.94 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 30,156 | 27.7 K to 30.2 K (+9.04 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 30.04 | 200 | 6,008 | 27,656 | 27.9 K to 27.7 K (-0.72 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 29.71 | 7,300 | 216,883 | 27,856 | 35.2 K to 27.9 K (-20.76 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 7,500 | 38,100 | 35,156 | 27.7 K to 35.2 K (+27.12 %) |